US biotech Illumina faces steep loss from forced sale of Grail 0 18.06.2024 13:00 Financial Times Shares in cancer-test developer trading in low volumes ahead of spin-off demanded by antitrust regulators Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
